FAP and neoplasm: In addition, the tumor uptake of 131I-FAP-2286 in the blocking group was significantly lower than that in the non-blocking group ((0.0067 ± 0.0001%ID/mL) vs (0.0233 ± 0.0026%ID/mL), P = 0.032) (Fig. 5C).